Description

(6R,6Ar)-6,6A,11,14-Tetrahydro-8,9-Dimethoxy-6-Methyl-12H-Benzo[A]-1,3-Benzodioxolo[4,5-G]Quinolizine is a complex, high-purity alkaloid derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound matters as a sophisticated chiral building block and a key intermediate for developing novel bioactive molecules, particularly in the realm of central nervous system (CNS) agents. It is primarily needed by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers focused on developing new therapeutic candidates, especially those targeting neurological pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical chiral precursor in the synthesis of potential therapeutic agents, particularly for neurological and psychiatric drug discovery programs.
• Biochemical Research: Used as a reference standard or a ligand in pharmacological studies to investigate receptor binding and enzyme inhibition mechanisms.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct intricate polycyclic frameworks found in natural products and medicinal chemistry targets.
• Analytical Standard: Provides a high-purity benchmark for method development and quality control in analytical laboratories, including HPLC and LC-MS analysis.
• Asymmetric Catalysis Studies: Utilized as a substrate or a model compound in the development and testing of new chiral catalysts and synthetic methodologies.

Basic Information

Item	Details
Product Name	(6R,6Ar)-6,6A,11,14-Tetrahydro-8,9-Dimethoxy-6-Methyl-12H-Benzo[A]-1,3-Benzodioxolo[4,5-G]Quinolizine
CAS No.	30342-06-4
Molecular Formula	C21H23NO4
Molecular Weight	353.41 g/mol
Synonyms	6,6A,11,14-Tetrahydro-8,9-dimethoxy-6-methyl-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizine; (6R,6aR)-6,6a,11,14-Tetrahydro-8,9-dimethoxy-6-methyl-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizine; 6-Methyl-8,9-dimethoxy-6,6a,11,14-tetrahydro-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizine; Aporphine alkaloid derivative; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our (6R,6Ar)-6,6A,11,14-Tetrahydro-8,9-Dimethoxy-6-Methyl-12H-Benzo[A]-1,3-Benzodioxolo[4,5-G]Quinolizine is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure compliance with research-grade standards. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and should be handled under appropriate conditions to maintain stability. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.